Finance

Lists
SRZN:NASDAQ
Surrozen Inc
$31.61
-0.19%
(-0.060) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SRZN...
Open
$32.34
High
$32.87
Low
$30.40
Mkt. cap
602.54M
Avg. vol.
422.34K
Volume
106.74K
52-wk high
$37.83
52-wk low
$12.31
EPS
-$35.79
Beta
0.51
Shares outstanding
19.06M
No. of employees
44
Open
$32.34
High
$32.87
Low
$30.40
Mkt. cap
602.54M
Avg. vol.
422.34K
Volume
106.74K
52-wk high
$37.83
52-wk low
$12.31
EPS
-$35.79
Beta
0.51
Shares outstanding
19.06M
No. of employees
44
News stories
From web sources and news partners
About Surrozen Inc
CEO-
Employees44
Founded2015
HeadquartersSouth San Francisco, California, United States
SectorHealth Care
IndustryBiotechnology
Websitesurrozen.com
Analyst ratings
Based on 6 analysts giving stock ratings to SRZN in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SRZN in the last 3 months.
Highest
Current $31.61
$80.00 (+153.08%)
Average
$62.50 (+97.72%)
Lowest
$54.00 (+70.83%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yatin Suneja
Guggenheim
Buy
Maintained
$80.00
+153.1%
11/11/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$80.00
+153.1%
11/11/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$62.00
+96.1%
11/10/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
$54.00
+70.8%
11/10/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
10/12/2026
Patrick Dolezal
LifeSci Capital
Buy
Maintained
$54.00
+70.8%
10/11/2026
Lachlan Hanbury Brown
William Blair
Buy
Maintained
-
-
10/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
528.00K
5.00M
5.00M
-
Cost of goods sold
8.99M
9.33M
8.48M
10.84M
Cost of revenue
8.99M
9.33M
8.48M
10.84M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.18M
6.13M
6.89M
6.80M
Operating expense
4.18M
6.13M
6.89M
6.80M
Total operating expenses
13.17M
15.46M
15.37M
17.64M
Operating income
-12.64M
-10.46M
-10.37M
-17.64M
Other non operating income
-171.31M
-117.96M
59.61M
-112.99M
EBT including unusual items
-183.16M
-127.50M
50.18M
-129.72M
EBT excluding unusual items
-183.16M
-127.50M
50.18M
-129.72M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-183.16M
-127.50M
50.18M
-129.72M
Net profit margin
-34,689.20%
-2,550.10%
1,003.54%
-
Earnings per share
-9.62
-4.63
-2.10
-4.75
Interest and investment income
788.00K
912.00K
938.00K
912.00K
Interest expense
-
-
-
-
Net interest expenses
788.00K
912.00K
938.00K
912.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.59M
-10.39M
-10.32M
-17.59M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps